The epidemiology of nonalcoholic steatohepatitis.
作者信息
Younossi Zobair M
机构信息
Center for Liver Disease, Department of Medicine Inova Fairfax Hospital Falls Church VA.
Betty and Guy Beatty Center for Integrated Research Inova Health System Falls Church VA.
出版信息
Clin Liver Dis (Hoboken). 2018 Apr 20;11(4):92-94. doi: 10.1002/cld.710. eCollection 2018 Apr.
Abstract
摘要
相似文献
1
The epidemiology of nonalcoholic steatohepatitis.非酒精性脂肪性肝炎的流行病学
Clin Liver Dis (Hoboken). 2018 Apr 20;11(4):92-94. doi: 10.1002/cld.710. eCollection 2018 Apr.
2
Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World.非酒精性脂肪性肝病和非酒精性脂肪性肝炎在美国和世界其他地区的流行病学。
Clin Liver Dis. 2016 May;20(2):205-14. doi: 10.1016/j.cld.2015.10.001. Epub 2015 Dec 14.
3
Nonalcoholic Steatohepatitis Is the Most Rapidly Growing Indication for Liver Transplantation in Iranian Patients.非酒精性脂肪性肝炎是伊朗患者进行肝移植的增长最快的指征。
Exp Clin Transplant. 2022 May;20(5):487-494. doi: 10.6002/ect.2019.0205. Epub 2019 Oct 1.
4
Nonalcoholic fatty liver disease: scintigraphy in the diagnosis of steatohepatitis.非酒精性脂肪性肝病：肝脂肪性肝炎的闪烁显像诊断。
Rev Assoc Med Bras (1992). 2021 Nov;67(11):1665-1669. doi: 10.1590/1806-9282.20210718.
5
Prevalence of nonalcoholic steatohepatitis among patients with resectable intrahepatic cholangiocarcinoma.可切除性肝内胆管细胞癌患者中非酒精性脂肪性肝炎的患病率。
J Gastrointest Surg. 2013 Apr;17(4):748-55. doi: 10.1007/s11605-013-2149-x. Epub 2013 Jan 25.
6
[The importance of AST / ALT rate in nonalcoholic steatohepatitis diagnosis].[谷草转氨酶/谷丙转氨酶比值在非酒精性脂肪性肝炎诊断中的重要性]
Arq Gastroenterol. 2002 Jan-Mar;39(1):22-6. doi: 10.1590/s0004-28032002000100005.
7
Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine.利用高脂、胆碱缺乏饮食和腹腔注射二乙基亚硝胺建立一种伴有非酒精性脂肪性肝炎的新型肝细胞癌小鼠模型。
BMC Gastroenterol. 2016 Jun 13;16(1):61. doi: 10.1186/s12876-016-0477-5.
8
Measurement of the total antioxidant response using a novel automated method in subjects with nonalcoholic steatohepatitis.使用一种新型自动化方法对非酒精性脂肪性肝炎患者的总抗氧化反应进行测量。
BMC Gastroenterol. 2005 Nov 11;5:35. doi: 10.1186/1471-230X-5-35.
9
Serum ubiquitin levels in patients with nonalcoholic steatohepatitis.非酒精性脂肪性肝炎患者的血清泛素水平
Hepatogastroenterology. 2003 May-Jun;50(51):738-41.
10
Adipokines in a group of Mexican patients with nonalcoholic steatohepatitis.一组墨西哥非酒精性脂肪性肝炎患者体内的脂肪因子
Ann Hepatol. 2009 Apr-Jun;8(2):123-8.
引用本文的文献
1
The role of probiotics on the roadmap to a healthy microbiota: a symposium report.益生菌在健康微生物群发展路径中的作用：研讨会报告
Gut Microbiome (Camb). 2020 Aug 26;1:e2. doi: 10.1017/gmb.2020.2. eCollection 2020.
2
Macrophage-Hepatocyte Circuits Mediated by Grancalcin Aggravate the Progression of Metabolic Dysfunction Associated Steatohepatitis.钙粒蛋白介导的巨噬细胞-肝细胞环路加剧代谢相关脂肪性肝炎的进展。
Adv Sci (Weinh). 2024 Nov;11(42):e2406500. doi: 10.1002/advs.202406500. Epub 2024 Sep 16.
3
Comparative efficacy of pharmacologic therapies for MASH in reducing liver fat content: Systematic review and network meta-analysis.药物治疗对非酒精性脂肪性肝炎（NASH）降低肝脏脂肪含量的比较疗效：系统评价与网状Meta分析
Hepatology. 2024 Jul 19. doi: 10.1097/HEP.0000000000001028.
4
Fetuin-A: a relevant novel serum biomarker for non-invasive diagnosis of metabolic dysfunction-associated steatotic liver disease (MASLD): a retrospective case-control study.胎球蛋白-A：一种用于代谢相关脂肪性肝病（MASLD）无创诊断的相关新型血清标志物：一项回顾性病例对照研究。
BMC Gastroenterol. 2024 Jul 18;24(1):226. doi: 10.1186/s12876-024-03310-y.
5
The Role of CD4T Cells in Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.CD4T 细胞在非酒精性脂肪性肝炎和肝细胞癌中的作用。
Int J Mol Sci. 2024 Jun 23;25(13):6895. doi: 10.3390/ijms25136895.
6
Time-Restricted Feeding Attenuates Metabolic Dysfunction-Associated Steatohepatitis and Hepatocellular Carcinoma in Obese Male Mice.限时进食可减轻肥胖雄性小鼠的代谢功能障碍相关脂肪性肝炎和肝细胞癌。
Cancers (Basel). 2024 Apr 16;16(8):1513. doi: 10.3390/cancers16081513.
7
A Markov model of fibrosis development in nonalcoholic fatty liver disease predicts fibrosis progression in clinical cohorts.一种非酒精性脂肪性肝病纤维化发展的马尔可夫模型可预测临床队列中的纤维化进展。
CPT Pharmacometrics Syst Pharmacol. 2023 Dec;12(12):2038-2049. doi: 10.1002/psp4.13052. Epub 2023 Oct 3.
8
Representative Rodent Models for Renal Transporter Alterations in Human Nonalcoholic Steatohepatitis.用于研究人类非酒精性脂肪性肝炎中肾脏转运蛋白改变的代表性啮齿类动物模型。
Drug Metab Dispos. 2023 Aug;51(8):970-981. doi: 10.1124/dmd.122.001133. Epub 2023 May 3.
9
Macrophage-derived Osteopontin (SPP1) Protects From Nonalcoholic Steatohepatitis.巨噬细胞来源的骨桥蛋白（SPP1）可预防非酒精性脂肪性肝炎。
Gastroenterology. 2023 Jul;165(1):201-217. doi: 10.1053/j.gastro.2023.03.228. Epub 2023 Apr 5.
10
High Fat Diet Mediated Alterations in Serum Sphingolipid Profiles in An Experimental Mouse Model Measured by Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry.高脂饮食介导的实验性小鼠模型血清鞘脂谱变化：通过基质辅助激光解吸/电离飞行时间质谱法测定
Eur J Biol Biotechnol. 2023 Feb;4(1):25-32. doi: 10.24018/ejbio.2023.4.1.135. Epub 2023 Feb 6.
本文引用的文献
1
Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的当前和未来治疗方案。
Hepatology. 2018 Jul;68(1):361-371. doi: 10.1002/hep.29724.
2
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的全球负担：趋势、预测、危险因素和预防。
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20. doi: 10.1038/nrgastro.2017.109. Epub 2017 Sep 20.
3
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease.对非酒精性脂肪性肝病流行情况的建模显示，疾病负担呈指数级增长。
Hepatology. 2018 Jan;67(1):123-133. doi: 10.1002/hep.29466. Epub 2017 Dec 1.
4
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.非酒精性脂肪性肝病的诊断与管理：美国肝病研究协会的实践指南
Hepatology. 2018 Jan;67(1):328-357. doi: 10.1002/hep.29367. Epub 2017 Sep 29.
5
Health Effects of Overweight and Obesity in 195 Countries over 25 Years.25年间195个国家超重和肥胖对健康的影响
N Engl J Med. 2017 Jul 6;377(1):13-27. doi: 10.1056/NEJMoa1614362. Epub 2017 Jun 12.
6
Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.等待肝移植的肝硬化或肝衰竭患者中丙型肝炎病毒感染、非酒精性脂肪性肝炎和酒精性肝病患病率的变化。
Gastroenterology. 2017 Apr;152(5):1090-1099.e1. doi: 10.1053/j.gastro.2017.01.003. Epub 2017 Jan 11.
7
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe.美国和欧洲非酒精性脂肪性肝病的经济和临床负担。
Hepatology. 2016 Nov;64(5):1577-1586. doi: 10.1002/hep.28785. Epub 2016 Sep 26.
8
Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World.非酒精性脂肪性肝病和非酒精性脂肪性肝炎在美国和世界其他地区的流行病学。
Clin Liver Dis. 2016 May;20(2):205-14. doi: 10.1016/j.cld.2015.10.001. Epub 2015 Dec 14.
9
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.全球非酒精性脂肪性肝病流行病学——患病率、发病率和结局的荟萃分析评估。
Hepatology. 2016 Jul;64(1):73-84. doi: 10.1002/hep.28431. Epub 2016 Feb 22.
10
Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009.2004 年至 2009 年美国非酒精性脂肪性肝病（NAFLD）与肝细胞癌（HCC）的相关性。
Hepatology. 2015 Dec;62(6):1723-30. doi: 10.1002/hep.28123. Epub 2015 Oct 24.
Zotero 插件